Bvf Inc Curis Inc Transaction History

Bvf Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$8.78 - $12.8 $5.5 Million - $8.02 Million	-626,945 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$1.08 - $8.2 $3.26 Million - $24.8 Million	-3,023,055 Reduced 82.82%	626,945 $5.14 Million
Q2 2020 Aug 14, 2020	BUY	$0.63 - $1.7 $2.3 Million - $6.21 Million	3,650,000 New	3,650,000 $4.42 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $320M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.